Teva Pays Out $225m To Settle Criminal Price-Fixing Charges In US
Glenmark Also Settles For $30m; Both Firms Must Divest Pravastatin As Part Of DoJ Deals
Teva has agreed to pay a $225m fine, as well as donating $50m worth of medicines and divesting a product from its portfolio, as part of a settlement with the US Department of Justice over criminal price-fixing charges. Meanwhile, Glenmark has also struck a $30m settlement with the DoJ.
